Jump Financial’s Immuneering IMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12,700
Closed -$63.4K – 2474
2026
Q2
$63.4K Buy
12,700
+450
+4% +$2.28K ﹤0.01% 1931
2026
Q1
$64.6K Buy
+12,250
New +$62.8K ﹤0.01% 1778
2022
Q2
– Sell
-19,300
Closed -$125K – 1804
2022
Q1
$125K Buy
+19,300
New +$185K 0.01% 1387

Other funds holding IMRX

Jump Financial's IMRX Position: Q3 2026 in Review

Jump Financial sold out of Immuneering (IMRX) in Q3 2026, closing a stake of 12,700 shares — an estimated $63.4K sold.

Jump Financial first reported a position in IMRX in Q1 2022 and held it in 3 quarters. The position peaked at $125K in Q1 2022. 131 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.

  • Jump Financial reported no remaining Immuneering position as of Q3 2026 after selling out during the quarter.
  • Jump Financial sold 12,700 Immuneering shares in Q3 2026, an estimated $63.4K.
  • Jump Financial first reported a position in Immuneering in Q1 2022 and held it in 3 quarters.
  • Jump Financial's Immuneering position peaked at $125K in Q1 2022.
  • 131 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.